Anavex Life Sciences Corporation
Most Recent
Why Anavex Life Sciences Stock Is Rising Today
Today, Anavex Life Sciences (AVXL) announced approval from the Australian Human Research Ethics Committee to initiate its Phase 2b/3 trial evaluating investigational therapy ANAVEX2-73 in early Alzheimers’ disease.
